TRON conducts collaborative research into immunological mechanisms and therapeutic modulation of the immune system. Specializing in cancer immunology and genomics, our research teams identify and characterize disease-relevant molecular targets, including developing tailored bioinformatical and novel biostatistical approaches. We design and improve cutting-edge technologies for biomarker discovery and biopharmaceutical drug development. In addition to our in-house projects, we offer a number of different project partnership models for both collaboration with academia and industry. We also have a wide range of highly specialized facility services available, which have been specially tailored to meet the needs of industry.